John Granton

Active 1996–2025

83
Papers
20,022
Citations
66
h-index
79
i10-index

Citations

Citations per year for John Granton1985: 1 citations1992: 1 citations1996: 1 citations1998: 3 citations1999: 11 citations2000: 15 citations2001: 11 citations2002: 12 citations2003: 20 citations2004: 30 citations2005: 53 citations2006: 48 citations2007: 62 citations2008: 77 citations2009: 81 citations2010: 107 citations2011: 65 citations2012: 92 citations2013: 130 citations2014: 111 citations2015: 147 citations2016: 144 citations2017: 159 citations2018: 152 citations2019: 449 citations2020: 454 citations2021: 443 citations2022: 330 citations2023: 374 citations2024: 750 citations2025: 312 citations2026: 14 citations1986–1991: no citations, so these years are not shown1993–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,754 citing papers, 21.6% of this breakdownUnited Kingdom: 652 citing papers, 8% of this breakdownCanada: 630 citing papers, 7.7% of this breakdownChina: 528 citing papers, 6.5% of this breakdownGermany: 464 citing papers, 5.7% of this breakdownItaly: 395 citing papers, 4.9% of this breakdownFrance: 386 citing papers, 4.7% of this breakdownNetherlands: 297 citing papers, 3.6% of this breakdownAustralia: 273 citing papers, 3.4% of this breakdownSwitzerland: 217 citing papers, 2.7% of this breakdownJapan: 212 citing papers, 2.6% of this breakdownSpain: 209 citing papers, 2.6% of this breakdown
0%21.6%Other 26%

Fields

  • Medicine86%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Health Professions1.8%
  • Engineering1.5%
  • Psychology1%
  • Immunology and Microbiology0.8%
  • Other3%

Topics

  • Pulmonary Hypertension Research and Treatments10.2%
  • Sepsis Diagnosis and Treatment5.3%
  • Respiratory Support and Mechanisms5%
  • Mesenchymal stem cell research3.4%
  • Intensive Care Unit Cognitive Disorders2.8%
  • Cardiovascular Function and Risk Factors2.6%
  • Other70.7%

Coauthors

All papers

Open in search
  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Markus Schwerzmann, Anh Tuan Dinh‐Xuan, Andy Bush, Magdy Abdelhamid, Victor Aboyans, Eloisa Arbustini, Riccardo Asteggiano, Joan Albert Barberà, Maurice Beghetti, Jelena Čelutkienė, Maja Čikeš, Robin Condliffe, Frances S. de Man, Volkmar Falk, Laurent Fauchier, Seán Gaine, Nazzareno Galiè, Wendy Gin‐Sing, John Granton, Ekkehard Grünig, Paul M. Hassoun, Merel E. Hellemons, Tiny Jaarsma, Barbro Kjellström, Frederikus A. Klok, А. О. Конради, Konstantinos C. Koskinas, Dipak Kotecha, Iréne Lang, Basil S. Lewis, Aleš Linhart, Gregory Y H Lip, Maja Lisa Løchen, Alexander G. Mathioudakis, Richard Mindham, Shahin Moledina, Robert Naeije, Jens Cosedis Nielsen, Horst Olschewski, Isabelle Opitz, Steffen E. Petersen, Eva Prescott, Amina Rakisheva, Abílio Reis, Arsen Ristić, Nicolás Roche, Rita Rodrigues, Christine Selton‐Suty, Rogério Souza, Andrew J. Swift, Rhian M. Touyz, Silvia Ulrich, Martin R. Wilkins, Stephen J. Wort - European Heart Journal 2022 cited by 3,652

  2. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,882

  3. Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

    Authors: , , , , , , , , - PLoS ONE 2012 cited by 1,140

  4. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles St.-Arnaud, Ian Ball, Dave Nagpal, Martin Girard, Pierre Aslanian, Emmanuel Charbonney, David Williamson, Wendy Sligl, Jan O. Friedrich, Neill K. J. Adhikari, François Marquis, Patrick Archambault, Kosar Khwaja, Arnold S. Kristof, James Kutsogiannis, Ryan Zarychanski, Bojan Paunovic, Brenda Reeve, François Lellouche, Paul Hosek, Jennifer Tsang, Alexandra Binnie, Sébastien Trop, Osama Loubani, Richard Hall, Robert Cirone, Steve Reynolds, Paul Lysecki, Eyal Golan, Rodrigo Cartin‐Ceba, Robert W. Taylor, Deborah Cook, Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT) Investigators and the Canadian Critical Care Trials Group, Christine Wallace, Gita Sobhi, Jennie Johnstone, François Lauzier, Deborah Cook, Erick Duan, Joanna C. Dionne, Bram Rochwerg, John Centoanti, Simon Oczkowski, Daphne Lamarche, Michael G. Surette, Dawn M. E. Bowdish, Andreas Laupacis, Robin Roberts, Christian Brun‐Buisson, Steve Reynolds, Sue Willems, Tina Sekhon, Peter Dodek, Najib Ayas, Maria Agda, Victoria Alcuaz, Betty-Jean Ashley, Kelsey Brewer, Janice L. Palmer, Glen Brown, Mara Pavan, William R. Henderson, Donald Greisdale, Mypinder S. Sekhon, Denise Foster, Suzie Logie, Judy Yip, Gordon Wood, Daniel Ovakim, F. C. Auld and 562 more - JAMA 2021 cited by 218

  5. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , - EClinicalMedicine 2020 cited by 276

  6. Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study

    Authors: , , , , , , , , , , , - BMJ Open Respiratory Research 2017 cited by 214

  7. Pharmacokinetic Alterations Associated with Critical Illness

    Authors: , , , - Clinical Pharmacokinetics 2023 cited by 150

  8. Strategies for lung- and diaphragm-protective ventilation in acute hypoxemic respiratory failure: a physiological trial

    Authors: , , , , , , , , , , , , , , , , - Critical Care 2022 cited by 122

  9. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , - CHEST Journal 2016 cited by 275

  10. Metabolomic Heterogeneity of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , - PLoS ONE 2014 cited by 143

  11. High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 895

  12. Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival

    Authors: , , , , , , , - Circulation Research 2005 cited by 325

  13. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension

    Authors: , , , - Respirology 2019 cited by 162

  14. Interobserver Variability in Applying a Radiographic Definition for ARDS

    Authors: , , , , - CHEST Journal 1999 cited by 385

  15. Intensive Care Unit Management of Patients with Severe Pulmonary Hypertension and Right Heart Failure

    Authors: , - American Journal of Respiratory and Critical Care Medicine 2011 cited by 309

  16. Oxygenation Response to Positive End-Expiratory Pressure Predicts Mortality in Acute Respiratory Distress Syndrome. A Secondary Analysis of the LOVS and ExPress Trials

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2014 cited by 187

  17. Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study

    Authors: , , , , , , , , , , , , , , - The American Journal of Medicine 2017 cited by 164

  18. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2021 cited by 75

  19. Bosentan Therapy in Patients With Eisenmenger Syndrome

    Authors: , , , , , , , - Circulation 2006 cited by 836

  20. Clinical trial design and new therapies for pulmonary arterial hypertension

    Authors: , , , , , , , , , - European Respiratory Journal 2018 cited by 195

  21. Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*

    Authors: , , , , , , , , , , , , , , , , , , , - Critical Care Medicine 2014 cited by 342

  22. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial

    Authors: , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 cited by 170

  23. Sleep Disordered Breathing in Group 1 Pulmonary Arterial Hypertension

    Authors: , , - Journal of Clinical Sleep Medicine 2014 cited by 91

  24. Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*

    Authors: , , , , , , , , , , , , - Critical Care Medicine 2019 cited by 76